Hhlr Advisors, Ltd. Portfolio Holdings

Hhlr Advisors, Ltd.

  • $3.26 Billion
  • Q1 2025

Hhlr Advisors, Ltd. has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $3.26 Billion distributed in 49 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pinduoduo Inc. with a value of $777M, Alibaba Group Holding LTD with a value of $517M, Futu Holdings LTD with a value of $441M, Net Ease, Inc. with a value of $275M, and Ke Holdings Inc. with a value of $241M.

Examining the 13F form we can see an increase of $645M in the current position value, from $2.61B to 3.26B.

Hhlr Advisors, Ltd. is based out at Grand Cayman, E9

Below you can find more details about Hhlr Advisors, Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $3.26 Billion
Consumer Cyclical: $1.7 Billion
Healthcare: $477 Million
Financial Services: $444 Million
Communication Services: $295 Million
Real Estate: $241 Million
Technology: $74.1 Million
Industrials: $25.7 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$128B
$777 Million 23.83% of portfolio
6,562,576
Q1 2025 Added 140.36%
$322B
$517 Million 15.86% of portfolio
3,907,755
Q1 2025 Reduced 20.04%
$16B
$441 Million 13.53% of portfolio
4,307,492
Q1 2025 Added 285.18%
$85.5B
$275 Million 8.43% of portfolio
2,668,697
Q1 2025 Added 3.08%
$23B
$241 Million 7.38% of portfolio
11,973,402
Q1 2025 Added 6.32%
$23.5B
$234 Million 7.2% of portfolio
1,034,306
Q1 2025 Reduced 72.81%
$5.82B
$203 Million 6.23% of portfolio
5,984,550
Q4 2024 Reduced 9.82%
$53B
$198 Million 6.07% of portfolio
4,811,700
Q1 2025 Added 184.72%
$9.57B
$105 Million 3.22% of portfolio
6,683,901
Q1 2025 Reduced 55.08%
$40B
$59.7 Million 1.83% of portfolio
938,842
Q1 2025 Added 2.74%
$721M
$55.5 Million 1.7% of portfolio
4,975,183
Q4 2021 New
$450M
$26.7 Million 0.82% of portfolio
6,657,030
Q2 2023 Reduced 13.58%
$29.4B
$15.6 Million 0.48% of portfolio
620,000
Q1 2025 New
$30.6B
$15.6 Million 0.48% of portfolio
170,000
Q1 2025 New
$18.5B
$15.2 Million 0.47% of portfolio
292,122
Q1 2025 New
$14.4B
$13.3 Million 0.41% of portfolio
671,387
Q1 2025 Added 54.01%
$11.2B
$8.78 Million 0.27% of portfolio
237,332
Q1 2025 New
$443M
$8.44 Million 0.26% of portfolio
2,098,553
Q4 2024 New
$118M
$5.47 Million 0.17% of portfolio
4,974,041
Q4 2022 Reduced 32.97%
$1.07T
$5.48 Million 0.17% of portfolio
33,000
Q1 2025 Reduced 22.51%
$190M
$4.9 Million 0.15% of portfolio
5,980,568
Q4 2024 Reduced 13.44%
$1.5B
$4.74 Million 0.15% of portfolio
1,564,400
Q1 2024 Reduced 2.21%
$282M
$4.42 Million 0.14% of portfolio
3,949,700
Q2 2023 Reduced 1.44%
$353M
$2.65 Million 0.08% of portfolio
201,432
Q1 2025 Reduced 60.54%
$17.7M
$1.87 Million 0.06% of portfolio
847,510
Q1 2023 Reduced 2.65%
$145B
$1.65 Million 0.05% of portfolio
8,026
Q1 2025 Reduced 38.63%
$2.93B
$1.43 Million 0.04% of portfolio
34,000
Q1 2025 Added 13.33%
$89B
$1.23 Million 0.04% of portfolio
2,637
Q1 2025 Reduced 41.1%
$44.6B
$1.2 Million 0.04% of portfolio
2,128
Q1 2025 Reduced 41.7%
$275B
$1.35 Million 0.04% of portfolio
6,757
Q1 2025 Reduced 34.58%
$2.32B
$947,000 0.03% of portfolio
100,000
Q1 2025 New
$225M
$1.08 Million 0.03% of portfolio
918,892
Q3 2023 New
$1.07B
$719,000 0.02% of portfolio
50,000
Q1 2025 New
Wns Hldgs LTD
-
$0 0.0% of portfolio
-
Q4 2024 New
Uxin LTD
-
$0 0.0% of portfolio
-
Q1 2024 New
Yatsen Hldg LTD
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 1.46%
Arrivent Biopharma Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 14.14%
Aligos Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
-
$0 0.0% of portfolio
-
Q1 2025 New
Contineum Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
China Yuchai Intl LTD
-
$0 0.0% of portfolio
-
Q1 2025 New
Maze Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Metagenomi Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 80.62%
Lakeshore Biopharma CO LTD
-
$0 0.0% of portfolio
-
Q4 2024 New
Ridgetech Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Ecarx Holdings Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Sagimet Biosciences Inc
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 50.0%
Bright Scholar Ed Hldgs LTD
-
$0 0.0% of portfolio
-
Q3 2023 Reduced 0.49%

Summary

  • Portfolio
  • No. of Stocks 49
  • Current Value $3.26 Billion
  • Prior Value $2.61 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 11 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 10 stocks
Track This Portfolio

Track Hhlr Advisors, Ltd. Portfolio

Follow Hhlr Advisors, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Hhlr Advisors, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email